A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes

Revista Española de Patología · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles